X-torial: Cleaning up the misinformation about @JoeBiden and #ProstateCancer that I am reading everywhere.
The purpose of this is to provide education from someone who treats and studies PCa for a living, lead the USA @NCCN PCa guidelines, hold leadership in @NRGonc@theNCI@US_FDA and dedicated my career to help men and their families suffering from PCa
@nytimes@WSJ@FoxNews@CNN@NBCNews@Reuters@ASCO@PCFnews @DeptofDefense
@BioprotectS@huntsmancancer@Huntsman_GU This is a very impressive perirectal spacer. I have done a bunch of cases now. Perfect space every time so far, adaptable, and moveable. Very easy to apply. An outstanding tool in a category with several good options
#ASCO23@asco PEACE-1 trial by Dr. Bossi👉Significant delay in disease progression and delay of serious GU obstructive events by radiation therapy in mCSPC (no OS benefit): results confirm the role of radiation in low volume denovo mCSPC @OncoAlert@urotoday@PCFnews
Alas! My medical scribes always get into medical school and leave me 😉. If you know a smart college grad who would like to work as my scribe/research assistant for at least 1 year @huntsmancancer . Please encourage them to apply: https://t.co/nRq4E6VAV7
Initial results of a phase 2 pilot study of radium-223 and radiotherapy in untreated hormone-naïve men with oligometastatic #ProstateCancer to bone. Presentation by @prostatemd@huntsmancancer. @ASCO#GU23 coverage by @WallisCJD > https://t.co/ZEwUluQFIX
Twitterverse Poll:
The ongoing healthcare financial crisis and workforce challenges will lead over 5 yrs…:
Comment other ideas!
I would appreciate if you reply and retweet to get a broad perspective.
@seanmmcbride@subatomicdoc@VPrasadMDMPH@EricTopol@ASCO@ASTRO_org